Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Belluscura PLC ( (GB:BELL) ) has shared an announcement.
Belluscura PLC announced a proposed equity fundraising to raise a minimum of £3.8 million through a placing of new shares and an additional £0.5 million via a retail offer to existing shareholders. The funds will be used to purchase inventory, support working capital, and strengthen the balance sheet. The announcement includes board changes, with several directors resigning and reassignments within its US subsidiary, Belluscura LLC. The fundraising and board restructuring are part of efforts to streamline operations and finance future growth.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in the development of oxygen enrichment technology. The company focuses on providing solutions across various industries and therapies, aiming to enhance respiratory care.
YTD Price Performance: -29.73%
Average Trading Volume: 149,443
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £10.95M
Find detailed analytics on BELL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue